Vericel Corporation (VCEL)
Vericel Corporation (VCEL) is a healthcare company (biotechnology) based in the United States. The share price is $58.50, up 1.77% on the day, which values the company at $2.99B. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.
Key facts
- Share price
- $58.50+1.77% today
- Market value
- $2.99B
- P/E ratio
- 91.4×last 12 months
- Forward P/E
- 62.1×
- Funk Score
- 57/100
- Against its own history
- Above its usual priceusual price $46.82
- 200-week average
- $40.6644% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Vericel Corporation in more detail
VCEL trades at 91.4× its last twelve months' earnings, 62.1× next year's expected earnings, 9.2× sales. Measured against its own history, the price is 25% above what its usual multiples would imply ($46.82) — above its usual price. It sits 44% above its 200-week average of $40.66.
Over the last five fiscal years Vericel Corporation has compounded revenue 17.8% a year, earnings per share 39.8% a year, free cash flow 10.6% a year. Its Funk Score is 57 out of 100 (financial strength 8.1, profitability 3.8, growth 8.8, value 1.9, each out of 10).
In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Share count keeps rising; Heavy stock-based pay.
Vericel Corporation (VCEL): questions and answers
What is VCEL's P/E ratio?
Vericel Corporation trades at 91.4× its last twelve months' earnings and 62.1× next year's expected earnings.
What is Vericel Corporation's market cap?
Vericel Corporation is valued at $2.99B at a share price of $58.50.
Is VCEL overvalued or undervalued?
Against its own history, VCEL is above its usual price: the price is 25% above the $46.82 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is VCEL above its 200-week moving average?
Yes. VCEL is 43.9% above its 200-week average of $40.66. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Vericel Corporation growing?
Over the last five fiscal years Vericel Corporation's revenue grew 17.8% a year and its earnings per share 39.8% a year; over ten years revenue grew 18.4% a year.
Does VCEL pay a dividend?
Vericel Corporation does not currently pay a regular dividend.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Vericel Corporation (VCEL) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VCEL
Underlying data: Yahoo Finance; company filings with the SEC.